The role of erk1 and erk2 in multiple stages of T cell development.
- Others:
- School of Biological Sciences [Univ California San Diego] (UC San Diego) ; University of California [San Diego] (UC San Diego) ; University of California (UC)-University of California (UC)
- Department of Cellular and Molecular Medicine ; University of California [San Diego] (UC San Diego) ; University of California (UC)-University of California (UC)
- Moores Cancer Center ; University of California [San Diego] (UC San Diego) ; University of California (UC)-University of California (UC)
- Institut de signalisation, biologie du développement et cancer (ISBDC) ; Université Nice Sophia Antipolis (1965 - 2019) (UNS) ; COMUE Université Côte d'Azur (2015-2019) (COMUE UCA)-COMUE Université Côte d'Azur (2015-2019) (COMUE UCA)-Centre National de la Recherche Scientifique (CNRS)-Université Côte d'Azur (UCA)
Description
Activation of extracellular-signal-regulated protein kinase (Erk) is central to growth-factor-receptor-mediated signaling including that originating from the T cell antigen receptor. It integrates cytoplasmic signals to effect changes in transcription associated with differentiation, proliferation, and survival. In this report, we present an analysis of mice with targeted deletions in Erk1 and Erk2 to assess the relationship between Erk activity and cell-cycle progression, thymocyte development, and lineage commitment. These studies show that Erk is selectively retained during beta selection-driven proliferation, and yet Erk1/2 are not required to complete differentiation to CD4+CD8+ preselection stage of development. Erk activity is essential for the process of positive selection, and it differentially affects CD4 and CD8 T cell maturation; yet, diminished expression itself is not sufficient to alter lineage commitment.
Abstract
International audience
Additional details
- URL
- https://hal.archives-ouvertes.fr/hal-00321595
- URN
- urn:oai:HAL:hal-00321595v1
- Origin repository
- UNICA